Caplin Point Laboratories Ltd. — Investor Relations & Filings
Caplin Point Laboratories Ltd. is a pharmaceutical organization focused on the development, manufacturing, and marketing of finished dosage forms. Its extensive product portfolio encompasses tablets, capsules, injections, liquid orals, and softgel capsules across diverse therapeutic categories. The company utilizes a vertically integrated business model, overseeing the complete value chain from research and development to final distribution. Caplin Point maintains a significant market presence in Latin America and Francophone Africa, supported by a specialized end-to-end logistics and supply chain network. Furthermore, through its subsidiary Caplin Steriles, the company has established a footprint in regulated markets, specializing in sterile injectables and ophthalmic products. Its manufacturing infrastructure is designed to meet global regulatory requirements, including certifications from the US FDA and EU GMP.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-07 | English | |
| Press Release | 2026-05-05 | English | |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-06 | English | |
| Trading Window | 2026-03-27 | English | |
| Press Release | 2026-03-13 | English | |
| Cessation | 2026-03-03 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 42853900 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-07 | English | ||
| 42193426 | Press Release | 2026-05-05 | English | ||
| 42209107 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-06 | English | ||
| 42213262 | Trading Window | 2026-03-27 | English | ||
| 42199015 | Press Release | 2026-03-13 | English | ||
| 42175465 | Cessation | 2026-03-03 | English | ||
| 42190574 | Press Release | 2026-02-28 | English | ||
| 42185175 | Press Release | 2026-02-24 | English | ||
| 42197934 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-02-11 | English | ||
| 42162579 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-02-05 | English | ||
| 42180729 | Investor Presentation | 2026-02-05 | English | ||
| 42183832 | Outcome of Board Meeting | 2026-02-05 | English | ||
| 42220110 | Change in Director(s) | 2026-02-03 | English | ||
| 42220381 | Shareholders meeting | 2026-02-03 | English | ||
| 42173993 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-01-29 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
CSPC Innovation Pharmaceutical Co.,Ltd.
Global supplier of caffeine, pharmaceutical ingredients, an…
|
300765 | CN | Manufacturing |
|
CSPC Pharmaceutical Group Limited
R&D, manufacturing, and sale of innovative finished and bul…
|
1093 | HK | Manufacturing |
|
CStone Pharmaceuticals
Innovation-driven biopharma focused on R&D and commercializ…
|
2616 | KY | Manufacturing |
|
CTC BIO, INC.
Develops and manufactures human and animal health products …
|
060590 | KR | Manufacturing |
|
Cue Biopharma, Inc.
Develops biologics to selectively modulate the immune syste…
|
CUE | US | Manufacturing |
|
Cullinan Therapeutics, Inc.
A clinical-stage biopharmaceutical company developing thera…
|
CGEM | US | Manufacturing |
|
CUMBERLAND PHARMACEUTICALS INC
Acquires, develops, and commercializes branded drugs for ho…
|
CPIX | US | Manufacturing |
|
Cuorips Inc.
Develops iPS cell-derived therapies and provides cell proce…
|
4894 | JP | Manufacturing |
|
Cuprina Holdings (Cayman) LTD
Biomedical firm developing wound care biotherapy and cosmec…
|
CUPR | US | Manufacturing |
|
Curaleaf
Cultivates, processes, and distributes medical and wellness…
|
CURA | CA | Manufacturing |
Caplin Point Laboratories Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/61439/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=61439 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=61439 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=61439 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 61439}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Caplin Point Laboratories Ltd. (id: 61439)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.